PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm CEO steps down & Appointment of MD, page-7

  1. 596 Posts.
    lightbulb Created with Sketch. 109
    We may never know the real reasons, but my gut says they would be sound and in the interests of Paradigm and its shareholders. I'm glad to have Paul Rennie back in any capacity. Big fan. Happy days!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.